vs
STANDARD BIOTOOLS INC.（LAB）与Chicago Atlantic Real Estate Finance, Inc.（REFI）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Chicago Atlantic Real Estate Finance, Inc.的1.4倍（$19.6M vs $14.2M），Chicago Atlantic Real Estate Finance, Inc.净利率更高（57.3% vs -177.4%，领先234.7%），Chicago Atlantic Real Estate Finance, Inc.同比增速更快（1.2% vs -11.5%），过去两年Chicago Atlantic Real Estate Finance, Inc.的营收复合增速更高（3.7% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Chicago Atlantic Real Estate Finance, Inc.是一家商业房地产金融企业，主要面向美国市场发起、承销和管理商业地产担保优先抵押贷款，服务多户住宅、工业、零售、办公等领域的资深地产运营商与项目发起人。
LAB vs REFI — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $14.2M |
| 净利润 | $-34.7M | $8.2M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 57.3% |
| 净利率 | -177.4% | 57.3% |
| 营收同比 | -11.5% | 1.2% |
| 净利润同比 | -28.8% | 3.0% |
| 每股收益（稀释后） | $-0.09 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $14.2M | ||
| Q3 25 | $19.6M | $13.7M | ||
| Q2 25 | $21.8M | $14.4M | ||
| Q1 25 | $40.8M | $13.0M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | $22.1M | $14.5M | ||
| Q2 24 | $22.5M | $13.2M | ||
| Q1 24 | $45.5M | $13.2M |
| Q4 25 | — | $8.2M | ||
| Q3 25 | $-34.7M | $8.9M | ||
| Q2 25 | $-33.5M | $8.9M | ||
| Q1 25 | $-26.0M | $10.0M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | $-26.9M | $11.2M | ||
| Q2 24 | $-45.7M | $9.2M | ||
| Q1 24 | $-32.2M | $8.7M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 57.3% | ||
| Q3 25 | -168.5% | 65.3% | ||
| Q2 25 | -118.1% | 61.5% | ||
| Q1 25 | -80.8% | 77.0% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | -120.9% | 77.5% | ||
| Q2 24 | -134.5% | 69.7% | ||
| Q1 24 | -132.2% | 65.9% |
| Q4 25 | — | 57.3% | ||
| Q3 25 | -177.4% | 65.3% | ||
| Q2 25 | -153.7% | 61.5% | ||
| Q1 25 | -63.8% | 77.0% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | -122.0% | 77.5% | ||
| Q2 24 | -203.3% | 69.7% | ||
| Q1 24 | -70.6% | 65.9% |
| Q4 25 | — | $0.38 | ||
| Q3 25 | $-0.09 | $0.42 | ||
| Q2 25 | $-0.09 | $0.41 | ||
| Q1 25 | $-0.07 | $0.47 | ||
| Q4 24 | — | $0.39 | ||
| Q3 24 | $-0.07 | $0.56 | ||
| Q2 24 | $-0.12 | $0.46 | ||
| Q1 24 | $-0.27 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $14.9M |
| 总债务越低越好 | — | $49.3M |
| 股东权益账面价值 | $399.7M | $307.8M |
| 总资产 | $539.6M | $424.9M |
| 负债/权益比越低杠杆越低 | — | 0.16× |
8季度趋势，按日历期对齐
| Q4 25 | — | $14.9M | ||
| Q3 25 | $129.4M | $28.9M | ||
| Q2 25 | $158.6M | $35.6M | ||
| Q1 25 | $150.9M | $9.9M | ||
| Q4 24 | — | $26.4M | ||
| Q3 24 | $210.6M | $6.8M | ||
| Q2 24 | $269.8M | $7.1M | ||
| Q1 24 | $287.1M | $6.9M |
| Q4 25 | — | $49.3M | ||
| Q3 25 | — | $49.3M | ||
| Q2 25 | — | $49.2M | ||
| Q1 25 | — | $49.2M | ||
| Q4 24 | — | $49.1M | ||
| Q3 24 | $55.2M | $54.0M | ||
| Q2 24 | $55.1M | $76.8M | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $307.8M | ||
| Q3 25 | $399.7M | $309.9M | ||
| Q2 25 | $424.5M | $310.0M | ||
| Q1 25 | $454.6M | $310.8M | ||
| Q4 24 | — | $309.0M | ||
| Q3 24 | $489.3M | $295.5M | ||
| Q2 24 | $510.3M | $292.7M | ||
| Q1 24 | $577.3M | $286.0M |
| Q4 25 | — | $424.9M | ||
| Q3 25 | $539.6M | $427.1M | ||
| Q2 25 | $557.0M | $455.2M | ||
| Q1 25 | $579.6M | $414.7M | ||
| Q4 24 | — | $435.1M | ||
| Q3 24 | $681.5M | $365.9M | ||
| Q2 24 | $708.7M | $386.5M | ||
| Q1 24 | $777.7M | $383.7M |
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.16× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | 0.11× | 0.18× | ||
| Q2 24 | 0.11× | 0.26× | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $28.8M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | 3.53× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $28.8M | ||
| Q3 25 | $-22.2M | $8.2M | ||
| Q2 25 | $-20.7M | $6.5M | ||
| Q1 25 | $-30.3M | $7.6M | ||
| Q4 24 | — | $23.2M | ||
| Q3 24 | $-27.9M | $8.2M | ||
| Q2 24 | $-39.0M | $6.2M | ||
| Q1 24 | $-62.5M | $6.9M |
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 0.76× | ||
| Q4 24 | — | 2.92× | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | — | 0.79× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
REFI
暂无分部数据
